Description
A centrally acting antihypertensive agonist that targets I1 imidazoline receptors with a Ki value of 7.1 nM and demonstrates weaker affinity for I2 (Ki = 5.2 µM) and α2-adrenergic receptors; induces autophagy as evidenced by a dose-dependent increase of LC3-II levels in PC12 cells
Formal name: N-(dicyclopropylmethyl)-4,5-dihydro-2-oxazolamine, 2E-butenedioate (2:1)
Synonyms: Oxaminozoline|S 3341
Molecular weight: 238.3
CAS: 207572-68-7
Purity: ≥98%
Formulation: A crystalline solid
Product Type|Biochemicals|Receptor Pharmacology|Agonists||Research Area|Cardiovascular System|Cardiovascular Diseases|Hypertension||Research Area|Neuroscience